Amrutanjan Health Care Ltd-$
Amrutanjan Health Care Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....
RESULTS
◆ Monitor Closely
LOW RISK
📅 Filed on BSE: 05 Aug 2026, 05:46 PM IST · BSE ID: 1d9f29ba-9d59-41a5-8d5f-c66f24dfda24
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board will meet on August 11, 2026, to announce its financial results for the quarter ending June 30, 2026.
🤖 AI Summary
- Amrutanjan Health Care Ltd's Board meeting scheduled for August 11, 2026, in Hyderabad.
- Purpose is to consider and approve Unaudited Financial Results for quarter ended June 30, 2026.
- Results will include the Limited Review Report by Statutory Auditors.
- Trading window for equity shares closed from July 1, 2026, until August 13, 2026.
👥 What This Means For Shareholders
✅
Action Required
Shareholders are not required to take any immediate action based on this intimation. The details of the financial results will be made public after the Board meeting.
👤
Who Is Affected
All shareholders are affected by the trading window closure, which prevents dealing in equity shares of the company from July 1, 2026, until August 13, 2026. This measure aligns with SEBI (PIT) Regulations, 2015.
🔍
Management Signal
Management is adhering to regulatory requirements by announcing the board meeting for financial results approval and communicating the trading window closure for insider trading prevention.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Board meeting on August 11, 2026 — await Unaudited Financial Results for Q1 FY27.
Trading window reopening — check for dealing in equity shares after August 13, 2026.
Limited Review Report — review details from Statutory Auditors post-results approval.
LOW RISK
This filing is a routine announcement of a board meeting for quarterly results approval.
💡 Investor Takeaway
Amrutanjan Health Care Ltd will disclose its unaudited financial results for the quarter ended June 30, 2026, following a Board meeting on August 11, 2026. The trading window is closed until August 13, 2026.
📅 Company Track Record
Amrutanjan Health Care Ltd reported FY26 revenue of INR Lakhs 50,255.27 and proposed a dividend of Rs. 2.90 per share in its May 13, 2026, filing. The company previously announced its FY26 audited results and dividend would be approved on May 8, 2026.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
When is Amrutanjan Health Care Ltd's Board meeting scheduled?
The meeting of the Board of Directors of Amrutanjan Health Care Ltd is scheduled for Tuesday, August 11, 2026, in Hyderabad.
What is the purpose of the upcoming Board meeting on August 11, 2026?
The purpose of the Board meeting is to consider and approve the Unaudited Financial Results along with the Limited Review Report by the Statutory Auditors for the quarter ended June 30, 2026.
What are the dates for Amrutanjan Health Care's trading window closure?
The trading window for dealing in equity shares of Amrutanjan Health Care Ltd is closed effective from July 1, 2026, and will remain closed till August 13, 2026.
Which SEBI regulation governs this intimation by Amrutanjan Health Care Ltd?
This intimation is made under Regulation 29(1) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
Questions based on this BSE filing only. For information purposes.